Antimicrobial resistance (AMR) is a tremendously important issue on a global scale- drug resistance, specifically to antibiotics, is on the rise, and R&D in antibiotics has not kept up. This AMR 'gap' won’t be closed without fixing how returns are awarded; it requires scrapping the traditional approach that ties revenues to volume for an innovative approach that rewards value. 'Delinkage' of value and volume is an exciting, emerging topic among those involved in the antibiotic space. This review will attempt to introduce some of the ideas central to resolving the AMR crisis.
Last year, New York City Mayor Michael Bloomberg, attempted to pass legislation prohibiting the sale of soda over 16 ounces in restaurants, movie theaters, and